Bayer AG (FRA:BAYA) Short Percentage of Float


FRA:BAYA Bayer AG FRA:BAYA
62 GF Score
Price €11.80
GF Value €6.80
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Bayer AG Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:BAYA vs LLY, JNJ, ABBV: Short Percentage of Float Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bayer AG Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Bayer AG's Short Percentage of Float falls into.


FRA:BAYA
62GF Score
Bayer AG FRA:BAYA
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (FRA:BAYA) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of €11.80 is trading 73.5% above its estimated GF Value™ of €6.80. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for FRA:BAYA:

  • Short Percentage of Float:
  • GF Value™: €6.80 vs. price of €11.80 (73.5% above fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the FRA:BAYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
62GF Score

Get the complete analysis for FRA:BAYA

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.80
Price
€6.80
GF Value